Email this article 
Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)
- Authors: Romanenko N.A.1, Abdulkadyrov K.M.1
-
Affiliations:
- Russian Research Institute of Hematology and Transfusiology, Russian Federal Medico-biological Agency
- Issue: Vol 6, No 3 (2011)
- Pages: 39-49
- Section: HEMATOLOGIC MALIGNANCIES: DIAGNOSIS, TREATMENT, SUPPORTIVE CARE
- Published: 23.08.2011
- URL: https://oncohematology.abvpress.ru/ongm/article/view/89
- DOI: https://doi.org/10.17650/1818-8346-2011-6-3-39-49
- ID: 89
Cite item
Full Text
Abstract
Literature review of anemia pathogenesis in patients with lymphatic system malignancies is presented. Advantages and disadvanta ges of eritropoiesis-stimulating preparations (ESP) used for anemia correction are shown. Efficacy of anemia treatment with ESP in various types of lymphoproliferative disorders (LPD) is presented. Prognostic factors that predict positive response on ESP in LPD pati ents and reduce treatment cost are identified.
About the authors
N. A. Romanenko
Russian Research Institute of Hematology and Transfusiology, Russian Federal Medico-biological Agency
Author for correspondence.
Email: rom-nik@yandex.ru
Russian Federation
K. M. Abdulkadyrov
Russian Research Institute of Hematology and Transfusiology, Russian Federal Medico-biological AgencyRussian Federation
References
Supplementary files
